HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroshi Maeda Selected Research

p-Chloromercuribenzoic Acid (PCMB)

1/2021Phosphorylcholine-Grafted Molecular Bottlebrush-Doxorubicin Conjugates: High Structural Stability, Long Circulation in Blood, and Efficient Anticancer Activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroshi Maeda Research Topics

Disease

85Neoplasms (Cancer)
01/2022 - 03/2002
10Colonic Neoplasms (Colon Cancer)
11/2020 - 03/2002
8Neoplasm Metastasis (Metastasis)
01/2022 - 03/2002
8Periodontitis
01/2020 - 06/2003
7Inflammation (Inflammations)
08/2022 - 04/2008
6Infections
10/2020 - 01/2003
6Breast Neoplasms (Breast Cancer)
07/2020 - 01/2005
5Hepatocellular Carcinoma (Hepatoma)
01/2022 - 02/2004
5Bacterial Infections (Bacterial Infection)
12/2017 - 06/2002
4Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
03/2022 - 12/2013
4Cardiotoxicity
07/2021 - 01/2009
4Hypertension (High Blood Pressure)
04/2016 - 04/2009
4Prostatic Neoplasms (Prostate Cancer)
02/2016 - 03/2004
4Carcinogenesis
12/2013 - 04/2008
3Thrombosis (Thrombus)
12/2020 - 10/2006
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2017 - 02/2008
3Colitis
02/2016 - 12/2013
3Periodontal Diseases (Periodontal Disease)
09/2015 - 10/2003
3Ischemia
12/2011 - 04/2009
3Reperfusion Injury
12/2011 - 04/2010
3Necrosis
08/2010 - 06/2003
2Chronic Granulomatous Disease
08/2022 - 06/2012
2Body Weight (Weight, Body)
08/2022 - 01/2020
2Macular Degeneration (Age-Related Maculopathy)
05/2021 - 01/2011
2Mycoses (Diseases, Fungus)
11/2020 - 12/2019
2Virus Diseases (Viral Diseases)
10/2020 - 01/2003

Drug/Important Bio-Agent (IBA)

43Pharmaceutical PreparationsIBA
01/2022 - 01/2003
15Therapeutic UsesIBA
05/2021 - 11/2004
13PolymersIBA
07/2021 - 08/2007
13pirarubicinIBA
07/2021 - 01/2005
13Antineoplastic Agents (Antineoplastics)IBA
01/2021 - 01/2003
12Styrene (Styrol)IBA
03/2022 - 03/2002
12maleic acid (maleate)IBA
03/2022 - 03/2002
10MicellesIBA
02/2016 - 06/2004
9zinc protoporphyrinIBA
05/2021 - 07/2003
9Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2016 - 03/2002
8Heme Oxygenase-1IBA
01/2016 - 03/2004
7Reactive Oxygen Species (Oxygen Radicals)IBA
08/2022 - 03/2004
7EnzymesIBA
08/2022 - 06/2002
7Doxorubicin (Adriamycin)FDA LinkGeneric
07/2021 - 06/2004
7Proteins (Proteins, Gene)FDA Link
01/2019 - 06/2004
7CytokinesIBA
02/2016 - 01/2003
7Messenger RNA (mRNA)IBA
03/2014 - 05/2002
6D-Amino-Acid Oxidase (D-Amino Acid Dehydrogenase)IBA
08/2022 - 06/2002
6Nitroglycerin (Dynamite)FDA LinkGeneric
04/2016 - 12/2009
5Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
08/2022 - 06/2002
5Carbon MonoxideIBA
03/2022 - 03/2004
5DuxonIBA
05/2021 - 02/2013
5LipidsIBA
01/2021 - 01/2003
5HydrazonesIBA
01/2021 - 01/2014
5CarcinogensIBA
07/2020 - 04/2008
5Dextran SulfateIBA
07/2020 - 12/2013
51-phenyl-3,3-dimethyltriazene (PDT)IBA
06/2019 - 11/2015
5N-(2-hydroxypropyl)methacrylamideIBA
06/2019 - 01/2014
5hydroxypropyl methacrylateIBA
01/2019 - 02/2013
5human S-nitrosoalbuminIBA
09/2017 - 02/2012
5ProstaglandinsIBA
04/2016 - 01/2003
5Evans Blue (Blue, Evans)FDA Link
11/2015 - 01/2003
4AlbuminsIBA
01/2021 - 01/2003
4anthraceneIBA
07/2020 - 12/2009
4Immunoglobulin G (IgG)IBA
01/2020 - 10/2008
4XenonIBA
09/2018 - 08/2007
4Biological ProductsIBA
12/2016 - 10/2014
4BradykininIBA
04/2016 - 03/2002
4Angiotensin IIIBA
04/2016 - 11/2009
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2016 - 06/2003
4copoly(styrene-maleic acid)-zinc protoporphyrinIBA
01/2016 - 04/2007
4Nitric Oxide Synthase (NO Synthase)IBA
10/2014 - 06/2002
4Heat-Shock Proteins (Heat-Shock Protein)IBA
03/2014 - 02/2008
3Anti-Bacterial Agents (Antibiotics)IBA
08/2022 - 10/2003
3AcidsIBA
01/2021 - 01/2014
3AzoxymethaneIBA
07/2020 - 12/2013
3Monoclonal AntibodiesIBA
01/2020 - 01/2005
3Singlet OxygenIBA
06/2019 - 08/2007
3Phosphotransferases (Kinase)IBA
03/2018 - 08/2009
3SolutionsIBA
01/2018 - 03/2008
3Xanthine OxidaseIBA
02/2016 - 04/2010
3Peptide Hydrolases (Proteases)FDA Link
01/2015 - 05/2010
3Hemin (Panhematin)FDA Link
06/2014 - 12/2011
34-vinyl-2,6-dimethoxyphenolIBA
12/2013 - 04/2008
3DNA (Deoxyribonucleic Acid)IBA
07/2013 - 04/2008
3Free RadicalsIBA
07/2013 - 01/2010
3Peroxynitrous Acid (Peroxynitrite)IBA
07/2013 - 03/2003
3poly(maleic acid-styrene)neocarzinostatin (zinostatin stimalamer)IBA
12/2012 - 03/2002
3Ethiodized Oil (Ethiodol)FDA Link
12/2012 - 03/2002
3Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
06/2012 - 06/2002
3pegylated zinc protoporphyrinIBA
08/2007 - 07/2003
2Tyrosine Kinase InhibitorsIBA
01/2022 - 01/2017
2AnthracyclinesIBA
07/2021 - 12/2009
2Glucosamine (Dona)IBA
05/2021 - 01/2021
2Cisplatin (Platino)FDA LinkGeneric
05/2021 - 02/2016
2boric acid (boron oxide hydroxide)IBA
05/2021 - 01/2021
2Amphotericin B (Amphotericin)FDA LinkGeneric
11/2020 - 12/2019
2AntioxidantsIBA
11/2020 - 11/2005

Therapy/Procedure

30Therapeutics
01/2022 - 06/2002
12Drug Therapy (Chemotherapy)
07/2021 - 08/2007
8Photochemotherapy (Photodynamic Therapy)
05/2021 - 08/2007
5Oral Administration
02/2016 - 08/2009
2Radiotherapy
01/2022 - 02/2016
2Precision Medicine
03/2021 - 09/2018